Quest Diagnostics (DGX) Tax Provisions (2009 - 2026)

Quest Diagnostics has reported Tax Provisions for 18 years, with the latest figure at $88.0 million in Q2 2026.

• Quarterly Tax Provisions fell 9.28% year-over-year to $88.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $320.0 million (up 10.73% YoY) and the FY2025 annual result came in at $314.0 million, up 15.02% from the prior year.
• Tax Provisions climbed to $88.0 million in Q2 2026 per DGX's latest filing, from $74.0 million in the prior quarter.
• Over five years, Tax Provisions peaked at $110.0 million in Q1 2022 and troughed at -$4.0 million in Q4 2022.
• A 5-year average of $70.1 million and a median of $74.0 million in 2024 frame the typical range for Tax Provisions.
• The sharpest annual moves came in 2022 and 2023: Tax Provisions plunged 103.51% in 2022, then surged 1100.0% in 2023.
• Over 5 years, Tax Provisions stood at -$4.0 million in 2022, then soared by 1100.0% to $40.0 million in 2023, then surged by 70.0% to $68.0 million in 2024, then rose by 19.12% to $81.0 million in 2025, then rose by 8.64% to $88.0 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $88.0 million, $74.0 million, and $81.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.